Diagnostic Revenues Drive up CombiMatrix Q2 Revenues 31 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix today reported a 31 percent increase year over year in its second-quarter revenues on an uptick in its diagnostic testing service revenues.

For the three months ended June 30, the firm posted revenues of $1.2 million, compared to $916,000 a year ago. Total revenues were comprised completely of diagnostic testing revenues, which rose 51 percent from $796,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.